Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasion

Phosphoinositide signaling pathway has garnered significant attention in recent years due to its implication in metabolic alterations associated with various human diseases, including breast cancer. Phosphatidylinositol-5-phosphate 4-kinase (PIP4K) catalyzes the phosphorylation of phosphatidylinosit...

Full description

Saved in:
Bibliographic Details
Main Authors: Yue Jin, Jian Xue, Xinyue Li, Xiaoli Zhong
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Translational Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523325001512
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849387317722087424
author Yue Jin
Jian Xue
Xinyue Li
Xiaoli Zhong
author_facet Yue Jin
Jian Xue
Xinyue Li
Xiaoli Zhong
author_sort Yue Jin
collection DOAJ
description Phosphoinositide signaling pathway has garnered significant attention in recent years due to its implication in metabolic alterations associated with various human diseases, including breast cancer. Phosphatidylinositol-5-phosphate 4-kinase (PIP4K) catalyzes the phosphorylation of phosphatidylinositol-5-phosphate (PI5P) to produce phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2), a lipid that regulates signaling pathways associated with cancer cell growth and metastasis. In breast cancer, PIP4Ks, especially PIP4Kα and PIP4Kβ, have emerged as a significant player, with their dysregulation linked to tumor progression and poor prognosis. However, the role of PIP4Kγ (encoded by PIP4K2C), the other isoform of PIP4K family, remains largely uncharted in breast cancer. Here, we demonstrated that the expression of PIP4K2C is upregulated in breast cancer tissues opposed to the normal tissue utilizing the GTEx and the TCGA public database. The elevation of PIP4K2C expression is further confirmed in the breast cancer cell lines and tissues. Downregulated expression of PIP4K2C by siRNA lowered the subcellular PI(4,5)P2 and suppressed proliferation, migration and invasion of MDA-MB-468, MCF7 breast cancer cell lines. Our research substantiates PIP4K2C as a promising diagnostic and therapeutic biomarker for breast cancer, warranting further investigation into its mechanistic and clinical implications.
format Article
id doaj-art-9f59637709ea4d919c1759d1070655d0
institution Kabale University
issn 1936-5233
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Translational Oncology
spelling doaj-art-9f59637709ea4d919c1759d1070655d02025-08-20T03:53:52ZengElsevierTranslational Oncology1936-52332025-07-015710242010.1016/j.tranon.2025.102420Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasionYue Jin0Jian Xue1Xinyue Li2Xiaoli Zhong3Department of Medical Research Center, Northern Jiangsu People's Hospital, Jiangsu, Yangzhou, 225001, PR ChinaDepartment of Emergency Medicine, Yizheng People’s Hospital, Jiangsu, Yangzhou, 211400, PR ChinaDepartment of Molecular Diagnosis, Northern Jiangsu People's Hospital, Jiangsu, Yangzhou, 225001, , PR ChinaMedical College, Yangzhou University, Jiangsu, Yangzhou, 225009, PR China; Corresponding author.Phosphoinositide signaling pathway has garnered significant attention in recent years due to its implication in metabolic alterations associated with various human diseases, including breast cancer. Phosphatidylinositol-5-phosphate 4-kinase (PIP4K) catalyzes the phosphorylation of phosphatidylinositol-5-phosphate (PI5P) to produce phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2), a lipid that regulates signaling pathways associated with cancer cell growth and metastasis. In breast cancer, PIP4Ks, especially PIP4Kα and PIP4Kβ, have emerged as a significant player, with their dysregulation linked to tumor progression and poor prognosis. However, the role of PIP4Kγ (encoded by PIP4K2C), the other isoform of PIP4K family, remains largely uncharted in breast cancer. Here, we demonstrated that the expression of PIP4K2C is upregulated in breast cancer tissues opposed to the normal tissue utilizing the GTEx and the TCGA public database. The elevation of PIP4K2C expression is further confirmed in the breast cancer cell lines and tissues. Downregulated expression of PIP4K2C by siRNA lowered the subcellular PI(4,5)P2 and suppressed proliferation, migration and invasion of MDA-MB-468, MCF7 breast cancer cell lines. Our research substantiates PIP4K2C as a promising diagnostic and therapeutic biomarker for breast cancer, warranting further investigation into its mechanistic and clinical implications.http://www.sciencedirect.com/science/article/pii/S1936523325001512Breast cancerPhosphoinositide kinasesPIP4K2CPI(4,5)P2
spellingShingle Yue Jin
Jian Xue
Xinyue Li
Xiaoli Zhong
Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasion
Translational Oncology
Breast cancer
Phosphoinositide kinases
PIP4K2C
PI(4,5)P2
title Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasion
title_full Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasion
title_fullStr Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasion
title_full_unstemmed Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasion
title_short Downregulation of PIP4K2C inhibits the breast cancer cell proliferation, migration and invasion
title_sort downregulation of pip4k2c inhibits the breast cancer cell proliferation migration and invasion
topic Breast cancer
Phosphoinositide kinases
PIP4K2C
PI(4,5)P2
url http://www.sciencedirect.com/science/article/pii/S1936523325001512
work_keys_str_mv AT yuejin downregulationofpip4k2cinhibitsthebreastcancercellproliferationmigrationandinvasion
AT jianxue downregulationofpip4k2cinhibitsthebreastcancercellproliferationmigrationandinvasion
AT xinyueli downregulationofpip4k2cinhibitsthebreastcancercellproliferationmigrationandinvasion
AT xiaolizhong downregulationofpip4k2cinhibitsthebreastcancercellproliferationmigrationandinvasion